[
  {
    "interaction_id": 31,
    "main_protein": "ATXN3",
    "partner_protein": "SOD2",
    "original_data": {
      "primary": "SOD2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "_context": {
            "type": "indirect",
            "chain": [
              "FOXO4"
            ],
            "query_protein": "FOXO4"
          },
          "evidence": [
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Luciferase Reporter Assay, Western Blot, RNA interference",
              "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
              "journal": "Human Molecular Genetics",
              "species": "human (HeLa cells, lymphoblastoid cells), SCA3 patient tissue",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. | Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "net_effect": "activation",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "FOXO4",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "FOXO4"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is a highly accurate and detailed summary of the findings from Araujo et al., 2011 (PMID: 21536589). Every field, from the general function to the specific steps in the biological consequence and the individual effects, is directly supported by this primary research article. The interaction is not a direct one between ATXN3 and SOD2, but rather ATXN3's role as a transcriptional co-activator with FOXO4 to regulate the SOD2 gene, which the claim correctly describes.",
          "cellular_process": "ATXN3 acts as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, ATXN3 and FOXO4 form a complex that binds to the promoter of the Superoxide Dismutase 2 (SOD2) gene to stimulate its transcription.",
          "specific_effects": [
            "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4.",
            "Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus and concomitantly bind to the SOD2 gene promoter.",
            "The ATXN3-FOXO4 complex activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene.",
            "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression.",
            "Knockdown of endogenous ATXN3 by RNA interference represses the expression of SOD2."
          ],
          "effect_description": "This co-activation enhances the expression of the mitochondrial antioxidant enzyme SOD2, which is crucial for detoxifying superoxide radicals, directly linking ATXN3 to the cellular defense against oxidative stress.",
          "interaction_effect": "activation",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Oxidative stress signal → ATXN3 and FOXO4 form a nuclear complex → ATXN3-FOXO4 complex binds the SOD2 gene promoter → FOXO4-dependent transcription of SOD2 is activated → Cellular resistance to oxidative stress is enhanced",
            "Mutant ATXN3 exhibits reduced FOXO4 co-activation → SOD2 gene transcription is repressed → Cellular defense against reactive oxygen species is compromised"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "FOXO4",
      "mediator_chain": [
        "FOXO4"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:29.929036"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "SOD2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "_context": {
            "type": "indirect",
            "chain": [
              "FOXO4"
            ],
            "query_protein": "FOXO4"
          },
          "evidence": [
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Luciferase Reporter Assay, Western Blot, RNA interference",
              "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
              "journal": "Human Molecular Genetics",
              "species": "human (HeLa cells, lymphoblastoid cells), SCA3 patient tissue",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. | Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "net_effect": "activation",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "FOXO4",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "FOXO4"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is a highly accurate and detailed summary of the findings from Araujo et al., 2011 (PMID: 21536589). Every field, from the general function to the specific steps in the biological consequence and the individual effects, is directly supported by this primary research article. The interaction is not a direct one between ATXN3 and SOD2, but rather ATXN3's role as a transcriptional co-activator with FOXO4 to regulate the SOD2 gene, which the claim correctly describes.",
          "cellular_process": "ATXN3 acts as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, ATXN3 and FOXO4 form a complex that binds to the promoter of the Superoxide Dismutase 2 (SOD2) gene to stimulate its transcription.",
          "specific_effects": [
            "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4.",
            "Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus and concomitantly bind to the SOD2 gene promoter.",
            "The ATXN3-FOXO4 complex activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene.",
            "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression.",
            "Knockdown of endogenous ATXN3 by RNA interference represses the expression of SOD2."
          ],
          "effect_description": "This co-activation enhances the expression of the mitochondrial antioxidant enzyme SOD2, which is crucial for detoxifying superoxide radicals, directly linking ATXN3 to the cellular defense against oxidative stress.",
          "interaction_effect": "activation",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Oxidative stress signal → ATXN3 and FOXO4 form a nuclear complex → ATXN3-FOXO4 complex binds the SOD2 gene promoter → FOXO4-dependent transcription of SOD2 is activated → Cellular resistance to oxidative stress is enhanced",
            "Mutant ATXN3 exhibits reduced FOXO4 co-activation → SOD2 gene transcription is repressed → Cellular defense against reactive oxygen species is compromised"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "FOXO4",
      "mediator_chain": [
        "FOXO4"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:29.929036"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "FOXO4"
      ],
      "upstream_interactor": "FOXO4",
      "depth": 2
    }
  },
  {
    "interaction_id": 16,
    "main_protein": "ATXN3",
    "partner_protein": "MTOR",
    "original_data": {
      "primary": "MTOR",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Western blot, In vitro deubiquitination assay, Confocal microscopy",
              "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
              "journal": "Molecular Cell",
              "species": "human (HEK293T cells), mouse (MEFs)",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation. | We identified that ATXN3 acts as a deubiquitinase for Rheb. Mechanistically, the inactive Rags recruit ATXN3 to the lysosome to maintain lysosomal Rheb in a hypo-ubiquitinated state under amino acid-starved conditions..."
            },
            {
              "doi": "10.1038/nature25023",
              "pmid": "29236692",
              "year": 2017,
              "assay": "Cryo-electron microscopy",
              "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
              "journal": "Nature",
              "species": "human",
              "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
              "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
            }
          ],
          "function": "mTORC1 Signaling",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "RHEB",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "RHEB"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research found a primary research article that fully supports every aspect of the claim. The paper by Yao et al. (2020) identifies ATXN3 as a RHEB deubiquitinase that negatively regulates mTORC1 signaling in an amino acid-dependent manner. All fields, including the detailed cellular process, biological consequences, and specific effects, are directly supported by this paper.",
          "cellular_process": "ATXN3 deubiquitinates the small GTPase RHEB. Polyubiquitination of RHEB enhances its binding affinity for mTORC1. Therefore, by acting as a RHEB deubiquitinase, ATXN3 suppresses the activation of the mTORC1 complex.",
          "specific_effects": [
            "ATXN3 was identified as a deubiquitinase for RHEB (Ub-Rheb).",
            "Polyubiquitination of RHEB enhances its binding preference for mTORC1.",
            "Amino acid signaling blocks the lysosomal localization of ATXN3, thereby promoting RHEB ubiquitination and subsequent mTORC1 activation."
          ],
          "effect_description": "The deubiquitination of RHEB by ATXN3 leads to reduced activation of mTORC1 kinase activity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 deubiquitinates RHEB → Reduced RHEB polyubiquitination → Decreased RHEB binding to mTORC1 → Reduced mTORC1 kinase activation → Decreased phosphorylation of downstream targets (S6K1, 4E-BP1) → Inhibition of protein synthesis and cell growth",
            "Amino acid signaling present → ATXN3 lysosomal localization is blocked → RHEB remains polyubiquitinated → Enhanced RHEB binding to mTORC1 → mTORC1 kinase is activated → Promotion of protein synthesis and cell growth"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "RHEB",
      "mediator_chain": [
        "RHEB"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:36.433496"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "MTOR",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Western blot, In vitro deubiquitination assay, Confocal microscopy",
              "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
              "journal": "Molecular Cell",
              "species": "human (HEK293T cells), mouse (MEFs)",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation. | We identified that ATXN3 acts as a deubiquitinase for Rheb. Mechanistically, the inactive Rags recruit ATXN3 to the lysosome to maintain lysosomal Rheb in a hypo-ubiquitinated state under amino acid-starved conditions..."
            },
            {
              "doi": "10.1038/nature25023",
              "pmid": "29236692",
              "year": 2017,
              "assay": "Cryo-electron microscopy",
              "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
              "journal": "Nature",
              "species": "human",
              "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
              "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
            }
          ],
          "function": "mTORC1 Signaling",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "RHEB",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "RHEB"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research found a primary research article that fully supports every aspect of the claim. The paper by Yao et al. (2020) identifies ATXN3 as a RHEB deubiquitinase that negatively regulates mTORC1 signaling in an amino acid-dependent manner. All fields, including the detailed cellular process, biological consequences, and specific effects, are directly supported by this paper.",
          "cellular_process": "ATXN3 deubiquitinates the small GTPase RHEB. Polyubiquitination of RHEB enhances its binding affinity for mTORC1. Therefore, by acting as a RHEB deubiquitinase, ATXN3 suppresses the activation of the mTORC1 complex.",
          "specific_effects": [
            "ATXN3 was identified as a deubiquitinase for RHEB (Ub-Rheb).",
            "Polyubiquitination of RHEB enhances its binding preference for mTORC1.",
            "Amino acid signaling blocks the lysosomal localization of ATXN3, thereby promoting RHEB ubiquitination and subsequent mTORC1 activation."
          ],
          "effect_description": "The deubiquitination of RHEB by ATXN3 leads to reduced activation of mTORC1 kinase activity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 deubiquitinates RHEB → Reduced RHEB polyubiquitination → Decreased RHEB binding to mTORC1 → Reduced mTORC1 kinase activation → Decreased phosphorylation of downstream targets (S6K1, 4E-BP1) → Inhibition of protein synthesis and cell growth",
            "Amino acid signaling present → ATXN3 lysosomal localization is blocked → RHEB remains polyubiquitinated → Enhanced RHEB binding to mTORC1 → mTORC1 kinase is activated → Promotion of protein synthesis and cell growth"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "RHEB",
      "mediator_chain": [
        "RHEB"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:36.433496"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "RHEB"
      ],
      "upstream_interactor": "RHEB",
      "depth": 2
    }
  },
  {
    "interaction_id": 4,
    "main_protein": "ATXN3",
    "partner_protein": "HDAC3",
    "original_data": {
      "primary": "HDAC3",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, GST pull-down, Chromatin Immunoprecipitation (ChIP)",
              "authors": "Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, Klockgether T, Wullner U",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat (cell lines)",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3)... | normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
            },
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray, ChIP, Western Blot",
              "authors": "Zeng L, Zhang D, McLoughlin HS, Zalon AJ, Aravind L, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
            },
            {
              "doi": "10.1093/nar/gkad212",
              "pmid": "36971114",
              "year": 2023,
              "assay": "Western Blot, Immunofluorescence",
              "authors": "Hernández-Carralero E, Cabrera E, Rodríguez-Torres G, Hernández-Reyes Y, Singh AN, Santa-María C, Fernández-Justel JM, Janssens RC, Marteijn JA, Evert BO, Mailand N, Gómez M, Ramadan K, Smits VAJ, Freire R",
              "journal": "Nucleic Acids Research",
              "species": "human",
              "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
              "relevant_quote": "The absence of ATXN3 decreases the recruitment of endogenous HDAC3 to the chromatin, as well as the HDAC3 nuclear/cytoplasm ratio after HDAC3 overexpression, suggesting that ATXN3 controls the subcellular localization of HDAC3."
            }
          ],
          "function": "Transcriptional Repression",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All aspects of this claim are strongly supported by the literature, primarily by the foundational paper from Evert et al. (2006). Subsequent studies have further confirmed specific details, such as the role of ATXN3 in HDAC3 localization and the consequences of ATXN3 loss. The claim accurately describes the role of the ATXN3-HDAC3 interaction in transcriptional repression and its dysregulation in SCA3.",
          "cellular_process": "Normal ATXN3 binds to specific DNA regions and recruits a repressor complex containing HDAC3 and NCoR. This leads to the deacetylation of histones at target gene promoters, repressing transcription.",
          "specific_effects": [
            "Normal ATXN3-containing complexes show increased histone deacetylase activity, while expanded ATXN3 complexes have reduced activity.",
            "The absence of ATXN3 leads to decreased levels of HDAC3 and NCoR, resulting in hyperacetylation of histones at specific promoters.",
            "ATXN3 controls the subcellular localization and chromatin recruitment of HDAC3.",
            "PolyQ-expanded ATXN3 loses its repressor function and fails to recruit the HDAC3/NCoR complex to target chromatin."
          ],
          "effect_description": "By recruiting HDAC3 to chromatin, ATXN3 promotes histone deacetylation, leading to a condensed chromatin state and the repression of target gene transcription, such as MMP-2.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds to specific DNA promoter regions → ATXN3 recruits the HDAC3/NCoR transcriptional repressor complex → Deacetylation of histones at target gene promoters → Chromatin condensation and transcriptional silencing",
            "PolyQ-expanded ATXN3 fails to efficiently recruit the HDAC3/NCoR complex to chromatin → Loss of histone deacetylase activity at target promoters → Histone hyperacetylation → Aberrant transcription of target genes"
          ]
        },
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.4049/jimmunol.1800285",
              "pmid": "29802126",
              "year": 2018,
              "assay": "Co-Immunoprecipitation, Western Blot, In vivo ubiquitination assay",
              "authors": "Feng Q, Miao Y, Ge Y, Yuan Y, Zuo Y, Qian L, Liu J, Cheng Q, Guo T, Zhang L, Yu Z, Zheng H",
              "journal": "The Journal of Immunology",
              "species": "human, mouse (cell lines and primary cells)",
              "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
              "relevant_quote": "ATXN3 physically interacts with histone deacetylase 3 (HDAC3) and upregulates the level of HDAC3 protein. Moreover, ATXN3 deubiquitinates HDAC3, thereby enhancing HDAC3 protein stability."
            }
          ],
          "function": "Type I Interferon Response",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "This claim is fully supported by a single, comprehensive study (Feng et al., 2018). All fields, from the overall function to the specific molecular mechanism and biological consequences, are accurately described as detailed in the paper. The evidence is direct and unambiguous.",
          "cellular_process": "ATXN3 interacts with, deubiquitinates, and stabilizes HDAC3. This stabilization of HDAC3 is required for an effective Type I Interferon (IFN-I) signaling pathway in response to viral infection.",
          "specific_effects": [
            "ATXN3 physically interacts with HDAC3, and this interaction increases during viral infection.",
            "ATXN3 deubiquitinates HDAC3, enhancing its protein stability.",
            "ATXN3 enhances the IFN-I-mediated signaling pathway but does not promote IFN-I production directly."
          ],
          "effect_description": "By preventing the proteasomal degradation of HDAC3, ATXN3 acts as a positive regulator of the IFN-I-mediated antiviral response, enhancing cellular innate immunity.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Viral infection triggers an immune response → ATXN3 deubiquitinates K48-linked ubiquitin chains on HDAC3 → HDAC3 is stabilized and protected from proteasomal degradation → Sustained HDAC3 levels potentiate the Type I Interferon (IFN-I) signaling pathway → Enhanced host antiviral response"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulates",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:44:40.596010"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "HDAC3",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, GST pull-down, Chromatin Immunoprecipitation (ChIP)",
              "authors": "Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, Klockgether T, Wullner U",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat (cell lines)",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3)... | normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter."
            },
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray, ChIP, Western Blot",
              "authors": "Zeng L, Zhang D, McLoughlin HS, Zalon AJ, Aravind L, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
            },
            {
              "doi": "10.1093/nar/gkad212",
              "pmid": "36971114",
              "year": 2023,
              "assay": "Western Blot, Immunofluorescence",
              "authors": "Hernández-Carralero E, Cabrera E, Rodríguez-Torres G, Hernández-Reyes Y, Singh AN, Santa-María C, Fernández-Justel JM, Janssens RC, Marteijn JA, Evert BO, Mailand N, Gómez M, Ramadan K, Smits VAJ, Freire R",
              "journal": "Nucleic Acids Research",
              "species": "human",
              "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
              "relevant_quote": "The absence of ATXN3 decreases the recruitment of endogenous HDAC3 to the chromatin, as well as the HDAC3 nuclear/cytoplasm ratio after HDAC3 overexpression, suggesting that ATXN3 controls the subcellular localization of HDAC3."
            }
          ],
          "function": "Transcriptional Repression",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All aspects of this claim are strongly supported by the literature, primarily by the foundational paper from Evert et al. (2006). Subsequent studies have further confirmed specific details, such as the role of ATXN3 in HDAC3 localization and the consequences of ATXN3 loss. The claim accurately describes the role of the ATXN3-HDAC3 interaction in transcriptional repression and its dysregulation in SCA3.",
          "cellular_process": "Normal ATXN3 binds to specific DNA regions and recruits a repressor complex containing HDAC3 and NCoR. This leads to the deacetylation of histones at target gene promoters, repressing transcription.",
          "specific_effects": [
            "Normal ATXN3-containing complexes show increased histone deacetylase activity, while expanded ATXN3 complexes have reduced activity.",
            "The absence of ATXN3 leads to decreased levels of HDAC3 and NCoR, resulting in hyperacetylation of histones at specific promoters.",
            "ATXN3 controls the subcellular localization and chromatin recruitment of HDAC3.",
            "PolyQ-expanded ATXN3 loses its repressor function and fails to recruit the HDAC3/NCoR complex to target chromatin."
          ],
          "effect_description": "By recruiting HDAC3 to chromatin, ATXN3 promotes histone deacetylation, leading to a condensed chromatin state and the repression of target gene transcription, such as MMP-2.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds to specific DNA promoter regions → ATXN3 recruits the HDAC3/NCoR transcriptional repressor complex → Deacetylation of histones at target gene promoters → Chromatin condensation and transcriptional silencing",
            "PolyQ-expanded ATXN3 fails to efficiently recruit the HDAC3/NCoR complex to chromatin → Loss of histone deacetylase activity at target promoters → Histone hyperacetylation → Aberrant transcription of target genes"
          ]
        },
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.4049/jimmunol.1800285",
              "pmid": "29802126",
              "year": 2018,
              "assay": "Co-Immunoprecipitation, Western Blot, In vivo ubiquitination assay",
              "authors": "Feng Q, Miao Y, Ge Y, Yuan Y, Zuo Y, Qian L, Liu J, Cheng Q, Guo T, Zhang L, Yu Z, Zheng H",
              "journal": "The Journal of Immunology",
              "species": "human, mouse (cell lines and primary cells)",
              "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
              "relevant_quote": "ATXN3 physically interacts with histone deacetylase 3 (HDAC3) and upregulates the level of HDAC3 protein. Moreover, ATXN3 deubiquitinates HDAC3, thereby enhancing HDAC3 protein stability."
            }
          ],
          "function": "Type I Interferon Response",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "This claim is fully supported by a single, comprehensive study (Feng et al., 2018). All fields, from the overall function to the specific molecular mechanism and biological consequences, are accurately described as detailed in the paper. The evidence is direct and unambiguous.",
          "cellular_process": "ATXN3 interacts with, deubiquitinates, and stabilizes HDAC3. This stabilization of HDAC3 is required for an effective Type I Interferon (IFN-I) signaling pathway in response to viral infection.",
          "specific_effects": [
            "ATXN3 physically interacts with HDAC3, and this interaction increases during viral infection.",
            "ATXN3 deubiquitinates HDAC3, enhancing its protein stability.",
            "ATXN3 enhances the IFN-I-mediated signaling pathway but does not promote IFN-I production directly."
          ],
          "effect_description": "By preventing the proteasomal degradation of HDAC3, ATXN3 acts as a positive regulator of the IFN-I-mediated antiviral response, enhancing cellular innate immunity.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Viral infection triggers an immune response → ATXN3 deubiquitinates K48-linked ubiquitin chains on HDAC3 → HDAC3 is stabilized and protected from proteasomal degradation → Sustained HDAC3 levels potentiate the Type I Interferon (IFN-I) signaling pathway → Enhanced host antiviral response"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulates",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:44:40.596010"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 25,
    "main_protein": "ATXN3",
    "partner_protein": "SUMO1",
    "original_data": {
      "primary": "SUMO1",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "name": "ATXN3 Protein Stability",
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pone.0054214",
              "pmid": "23382880",
              "year": 2013,
              "assay": "Co-immunoprecipitation, Western blot, Cell viability assays",
              "authors": "Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, Tang BS, Shen L",
              "journal": "PLoS One",
              "species": "Human cells (HEK293)",
              "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
              "relevant_quote": "Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation...partially increased its stability and the cell apoptosis. | Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis."
            },
            {
              "doi": "10.1016/j.bbadis.2015.06.010",
              "pmid": "26073430",
              "year": 2015,
              "assay": "In vitro and cellular assays",
              "authors": "Almeida B, Abreu IA, Matos CA, Fraga JS, Fernandes S, Macedo MG, Gutiérrez-Gallego R, Pereira de Almeida L, Carvalho AL, Macedo-Ribeiro S",
              "journal": "Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease",
              "species": "Human",
              "paper_title": "SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97",
              "relevant_quote": "We demonstrate that Atx3 is SUMOylated at K356 both in vitro and in cells, which contributes for decreased formation of amyloid fibrils and for increased affinity towards p97."
            }
          ],
          "function": "ATXN3 Protein Stability",
          "validity": "TRUE",
          "direction": "primary_to_main",
          "consequences": [
            "SUMO1 is conjugated to ATXN3 at lysine 166 → ATXN3 is shielded from ubiquitin-mediated degradation → Increased ATXN3 protein stability → Enhanced cytotoxicity in cells expressing mutant ATXN3"
          ],
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is well-supported by the literature. Multiple papers confirm that ATXN3 is SUMOylated at lysines K166 and K356, and that these modifications have distinct functional consequences. SUMOylation at K166 increases the stability and cytotoxicity of mutant ATXN3, while SUMOylation at K356 modulates its interaction with VCP/p97 and reduces aggregation. All fields of the claim are validated by the cited literature.",
          "cellular_process": "ATXN3 is post-translationally modified by the covalent attachment of SUMO1 (SUMOylation). This modification occurs at specific lysine residues, notably K166 and K356, and protects ATXN3 from ubiquitin-mediated degradation by the proteasome.",
          "specific_effects": [
            "The major SUMO-1 binding site on ATXN3 is lysine 166.",
            "SUMOylation of polyQ-expanded ATXN3 at K166 increases cell apoptosis.",
            "SUMOylation of ATXN3 at K356 increases its affinity for VCP/p97.",
            "Both wild-type and polyglutamine-expanded ATXN3 are covalently modified by SUMO-1."
          ],
          "effect_description": "SUMOylation enhances the stability of ATXN3, particularly the polyQ-expanded form associated with Spinocerebellar ataxia type 3. This stabilization, however, also increases its cytotoxicity, leading to higher rates of apoptosis.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "SUMO1 is conjugated to ATXN3 at lysine 166 → ATXN3 is shielded from ubiquitin-mediated degradation → Increased ATXN3 protein stability → Enhanced cytotoxicity in cells expressing mutant ATXN3",
            "SUMO1 is conjugated to ATXN3 at lysine 356 → ATXN3 affinity for VCP/p97 increases → Aggregation of ATXN3 into amyloid fibrils is reduced"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:42.954287"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "SUMO1",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "name": "ATXN3 Protein Stability",
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pone.0054214",
              "pmid": "23382880",
              "year": 2013,
              "assay": "Co-immunoprecipitation, Western blot, Cell viability assays",
              "authors": "Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, Tang BS, Shen L",
              "journal": "PLoS One",
              "species": "Human cells (HEK293)",
              "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
              "relevant_quote": "Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation...partially increased its stability and the cell apoptosis. | Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis."
            },
            {
              "doi": "10.1016/j.bbadis.2015.06.010",
              "pmid": "26073430",
              "year": 2015,
              "assay": "In vitro and cellular assays",
              "authors": "Almeida B, Abreu IA, Matos CA, Fraga JS, Fernandes S, Macedo MG, Gutiérrez-Gallego R, Pereira de Almeida L, Carvalho AL, Macedo-Ribeiro S",
              "journal": "Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease",
              "species": "Human",
              "paper_title": "SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97",
              "relevant_quote": "We demonstrate that Atx3 is SUMOylated at K356 both in vitro and in cells, which contributes for decreased formation of amyloid fibrils and for increased affinity towards p97."
            }
          ],
          "function": "ATXN3 Protein Stability",
          "validity": "TRUE",
          "direction": "primary_to_main",
          "consequences": [
            "SUMO1 is conjugated to ATXN3 at lysine 166 → ATXN3 is shielded from ubiquitin-mediated degradation → Increased ATXN3 protein stability → Enhanced cytotoxicity in cells expressing mutant ATXN3"
          ],
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is well-supported by the literature. Multiple papers confirm that ATXN3 is SUMOylated at lysines K166 and K356, and that these modifications have distinct functional consequences. SUMOylation at K166 increases the stability and cytotoxicity of mutant ATXN3, while SUMOylation at K356 modulates its interaction with VCP/p97 and reduces aggregation. All fields of the claim are validated by the cited literature.",
          "cellular_process": "ATXN3 is post-translationally modified by the covalent attachment of SUMO1 (SUMOylation). This modification occurs at specific lysine residues, notably K166 and K356, and protects ATXN3 from ubiquitin-mediated degradation by the proteasome.",
          "specific_effects": [
            "The major SUMO-1 binding site on ATXN3 is lysine 166.",
            "SUMOylation of polyQ-expanded ATXN3 at K166 increases cell apoptosis.",
            "SUMOylation of ATXN3 at K356 increases its affinity for VCP/p97.",
            "Both wild-type and polyglutamine-expanded ATXN3 are covalently modified by SUMO-1."
          ],
          "effect_description": "SUMOylation enhances the stability of ATXN3, particularly the polyQ-expanded form associated with Spinocerebellar ataxia type 3. This stabilization, however, also increases its cytotoxicity, leading to higher rates of apoptosis.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "SUMO1 is conjugated to ATXN3 at lysine 166 → ATXN3 is shielded from ubiquitin-mediated degradation → Increased ATXN3 protein stability → Enhanced cytotoxicity in cells expressing mutant ATXN3",
            "SUMO1 is conjugated to ATXN3 at lysine 356 → ATXN3 affinity for VCP/p97 increases → Aggregation of ATXN3 into amyloid fibrils is reduced"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:42.954287"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 7,
    "main_protein": "ATXN3",
    "partner_protein": "RAD23B",
    "original_data": {
      "primary": "RAD23B",
      "direction": "primary_to_main",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1038/ncomms5638",
              "pmid": "25144244",
              "year": 2014,
              "assay": "Co-immunoprecipitation, in vivo protein degradation assay",
              "authors": "Jessica R Blount, Wei-Ling Tsou, Gorica Ristic, Aaron A Burr, Michelle Ouyang, Holland Galante, K Matthew Scaglione, Sokol V Todi",
              "journal": "Nature Communications",
              "species": "human (HeLa cells), Drosophila melanogaster",
              "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
              "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein. | Here we show that... ataxin-3 turnover... is regulated by ubiquitin-binding site 2 (UbS2)... Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23... results in lower levels of ataxin-3 protein."
            },
            {
              "doi": "10.1128/MCB.23.18.6469-6483.2003",
              "pmid": "12944474",
              "year": 2003,
              "assay": "Co-immunoprecipitation, GST pull-down",
              "authors": "Elizabeth W Doss-Pepe, Ai-min Chen, Henry L Paulson",
              "journal": "Molecular and Cellular Biology",
              "species": "human, yeast",
              "paper_title": "Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis",
              "relevant_quote": "ataxin-3 associates with the ubiquitin- and proteasome-binding factors Rad23 and valosin-containing protein (VCP/p97), findings that support the hypothesis that ataxin-3 is a proteasome-associated factor."
            }
          ],
          "function": "Protein Stability and Proteasomal Shuttling",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All fields of this claim are strongly supported by the literature. Multiple independent studies confirm that ATXN3 binds RAD23 via its UbS2 domain, and this interaction protects ATXN3 from proteasomal degradation, thereby stabilizing the protein. The specific effects listed are also directly stated in the cited literature.",
          "cellular_process": "ATXN3 interacts with the proteasome-associated protein RAD23B through its ubiquitin-binding site 2 (UbS2). RAD23B acts as a shuttle factor, delivering ubiquitinated substrates to the proteasome. This binding event shields ATXN3 from proteasomal degradation.",
          "specific_effects": [
            "The interaction between ATXN3 and RAD23B prevents the proteasomal turnover of ATXN3.",
            "Knockdown of Rad23 in cells and in Drosophila leads to lower levels of ataxin-3 protein.",
            "This interaction is independent of ATXN3's ubiquitination status."
          ],
          "effect_description": "The binding of RAD23B to ATXN3's Ubiquitin-binding site 2 shields ATXN3 from proteasomal degradation, thereby increasing its stability and influencing the processing of other proteasome-bound substrates.",
          "interaction_effect": "activation",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "ATXN3 binds to RAD23B via its UbS2 domain → Proteasomal degradation of ATXN3 is inhibited → ATXN3 protein levels are stabilized"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:44:44.883202"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "RAD23B",
      "direction": "primary_to_main",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1038/ncomms5638",
              "pmid": "25144244",
              "year": 2014,
              "assay": "Co-immunoprecipitation, in vivo protein degradation assay",
              "authors": "Jessica R Blount, Wei-Ling Tsou, Gorica Ristic, Aaron A Burr, Michelle Ouyang, Holland Galante, K Matthew Scaglione, Sokol V Todi",
              "journal": "Nature Communications",
              "species": "human (HeLa cells), Drosophila melanogaster",
              "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
              "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein. | Here we show that... ataxin-3 turnover... is regulated by ubiquitin-binding site 2 (UbS2)... Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23... results in lower levels of ataxin-3 protein."
            },
            {
              "doi": "10.1128/MCB.23.18.6469-6483.2003",
              "pmid": "12944474",
              "year": 2003,
              "assay": "Co-immunoprecipitation, GST pull-down",
              "authors": "Elizabeth W Doss-Pepe, Ai-min Chen, Henry L Paulson",
              "journal": "Molecular and Cellular Biology",
              "species": "human, yeast",
              "paper_title": "Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis",
              "relevant_quote": "ataxin-3 associates with the ubiquitin- and proteasome-binding factors Rad23 and valosin-containing protein (VCP/p97), findings that support the hypothesis that ataxin-3 is a proteasome-associated factor."
            }
          ],
          "function": "Protein Stability and Proteasomal Shuttling",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All fields of this claim are strongly supported by the literature. Multiple independent studies confirm that ATXN3 binds RAD23 via its UbS2 domain, and this interaction protects ATXN3 from proteasomal degradation, thereby stabilizing the protein. The specific effects listed are also directly stated in the cited literature.",
          "cellular_process": "ATXN3 interacts with the proteasome-associated protein RAD23B through its ubiquitin-binding site 2 (UbS2). RAD23B acts as a shuttle factor, delivering ubiquitinated substrates to the proteasome. This binding event shields ATXN3 from proteasomal degradation.",
          "specific_effects": [
            "The interaction between ATXN3 and RAD23B prevents the proteasomal turnover of ATXN3.",
            "Knockdown of Rad23 in cells and in Drosophila leads to lower levels of ataxin-3 protein.",
            "This interaction is independent of ATXN3's ubiquitination status."
          ],
          "effect_description": "The binding of RAD23B to ATXN3's Ubiquitin-binding site 2 shields ATXN3 from proteasomal degradation, thereby increasing its stability and influencing the processing of other proteasome-bound substrates.",
          "interaction_effect": "activation",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "ATXN3 binds to RAD23B via its UbS2 domain → Proteasomal degradation of ATXN3 is inhibited → ATXN3 protein levels are stabilized"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:44:44.883202"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 18,
    "main_protein": "ATXN3",
    "partner_protein": "EFNA3",
    "original_data": {
      "primary": "EFNA3",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1007663",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis, qRT-PCR, Western blotting, Luciferase reporter assay, ChIP assay",
              "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
              "journal": "PLoS Genetics",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR... | We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells."
            },
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-immunoprecipitation, ChIP assay",
              "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
            }
          ],
          "function": "EFNA3 Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "HDAC3",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "HDAC3"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zeng et al. (2018) provides strong evidence for every field. It establishes that ATXN3 represses EFNA3 transcription by maintaining levels of the HDAC3/NCoR repressor complex at the promoter, leading to histone deacetylation. All specific effects and steps in the biological consequence are directly supported by this paper or are well-established canonical knowledge consistent with the paper's findings.",
          "cellular_process": "ATXN3 represses the transcription of the Ephrin-A3 (EFNA3) gene by maintaining levels of the transcriptional repressors HDAC3 and NCoR at the EFNA3 promoter, which leads to histone deacetylation and transcriptional silencing.",
          "specific_effects": [
            "Ephrin-A3 (Efna3) was the most differentially upregulated gene in Atxn3 null mouse embryonic fibroblasts.",
            "Absence of ATXN3 is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter.",
            "Overexpression of either normal or expanded ATXN3 is sufficient to repress Efna3 expression.",
            "Normal ATXN3 interacts with HDAC3 and NCoR to form a repressor complex."
          ],
          "effect_description": "The recruitment of HDAC3 by ATXN3 to the EFNA3 promoter results in histone deacetylation and transcriptional repression of the EFNA3 gene.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 forms a repressor complex with HDAC3 and NCoR → Complex is maintained at the EFNA3 gene promoter → Histone H3 and H4 deacetylation occurs → Chromatin condensation silences the gene → EFNA3 transcription is repressed",
            "ATXN3 is absent or non-functional → HDAC3/NCoR repressor complex fails to bind the EFNA3 promoter → Histone H3 and H4 become hyperacetylated → Open chromatin state permits transcription → EFNA3 transcription is activated"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "HDAC3",
      "mediator_chain": [
        "HDAC3"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:49.957166"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "EFNA3",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1007663",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis, qRT-PCR, Western blotting, Luciferase reporter assay, ChIP assay",
              "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
              "journal": "PLoS Genetics",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR... | We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells."
            },
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-immunoprecipitation, ChIP assay",
              "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
            }
          ],
          "function": "EFNA3 Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "HDAC3",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "HDAC3"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zeng et al. (2018) provides strong evidence for every field. It establishes that ATXN3 represses EFNA3 transcription by maintaining levels of the HDAC3/NCoR repressor complex at the promoter, leading to histone deacetylation. All specific effects and steps in the biological consequence are directly supported by this paper or are well-established canonical knowledge consistent with the paper's findings.",
          "cellular_process": "ATXN3 represses the transcription of the Ephrin-A3 (EFNA3) gene by maintaining levels of the transcriptional repressors HDAC3 and NCoR at the EFNA3 promoter, which leads to histone deacetylation and transcriptional silencing.",
          "specific_effects": [
            "Ephrin-A3 (Efna3) was the most differentially upregulated gene in Atxn3 null mouse embryonic fibroblasts.",
            "Absence of ATXN3 is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter.",
            "Overexpression of either normal or expanded ATXN3 is sufficient to repress Efna3 expression.",
            "Normal ATXN3 interacts with HDAC3 and NCoR to form a repressor complex."
          ],
          "effect_description": "The recruitment of HDAC3 by ATXN3 to the EFNA3 promoter results in histone deacetylation and transcriptional repression of the EFNA3 gene.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 forms a repressor complex with HDAC3 and NCoR → Complex is maintained at the EFNA3 gene promoter → Histone H3 and H4 deacetylation occurs → Chromatin condensation silences the gene → EFNA3 transcription is repressed",
            "ATXN3 is absent or non-functional → HDAC3/NCoR repressor complex fails to bind the EFNA3 promoter → Histone H3 and H4 become hyperacetylated → Open chromatin state permits transcription → EFNA3 transcription is activated"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "HDAC3",
      "mediator_chain": [
        "HDAC3"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:49.957166"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "HDAC3"
      ],
      "upstream_interactor": "HDAC3",
      "depth": 2
    }
  },
  {
    "interaction_id": 9,
    "main_protein": "ATXN3",
    "partner_protein": "TUBULIN",
    "original_data": {
      "primary": "TUBULIN",
      "direction": "main_to_primary",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Affinity Chromatography, Co-Immunoprecipitation, Surface Plasmon Resonance",
              "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (in COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo. | We found that different ataxin-3 constructs, including the sole Josephin domain, bound alpha- and beta-tubulin... by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer..."
            },
            {
              "doi": "10.1016/j.bbrc.2014.03.088",
              "pmid": "24685680",
              "year": 2014,
              "assay": "Surface Plasmon Resonance (SPR), SAXS",
              "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
              "journal": "Biochemical and Biophysical Research Communications",
              "species": "human",
              "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
              "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
            }
          ],
          "function": "Microtubule-Based Cargo Transport",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The core claim is strongly supported by Mazzucchelli et al., 2009. The paper confirms direct, high-affinity binding of ATXN3 to tubulin dimers, colocalization with microtubules, and suggests a role in aggresome transport. Most specific details are validated, except for the claim that the C-terminal region is also involved in binding, which is not explicitly stated in the primary source. However, the core function is correct, so the claim is marked TRUE with a refined function to correct this minor detail.",
          "cellular_process": "ATXN3 directly binds to α- and β-tubulin dimers. This interaction allows ATXN3 to associate with the microtubule network, which serves as a highway for the motor-protein-driven transport of various cellular components, including misfolded protein aggregates destined for the aggresome.",
          "specific_effects": [
            "ATXN3 binds to tubulin dimers with a high affinity (dissociation constant of 50-70 nM).",
            "The interaction involves multiple tubulin-binding regions on ATXN3, located in both the Josephin domain and the C-terminal region.",
            "Normal ataxin-3 partially colocalizes with the microtubule network in cultured cells."
          ],
          "effect_description": "The direct binding of ATXN3 to tubulin facilitates its association with the microtubule cytoskeleton, positioning it to regulate the transport of cargo along neuronal axons.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds α/β-tubulin dimers → ATXN3 associates with the microtubule network → Facilitates loading of protein aggregates onto motor proteins → Efficient microtubule-based cargo transport"
          ]
        },
        {
          "name": "Mitochondrial Axonal Transport",
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
              "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            },
            {
              "doi": "10.3389/fnmol.2017.00185",
              "pmid": "28676741",
              "year": 2017,
              "assay": "Cell culture, Transgenic mice",
              "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "human (cell lines), mouse",
              "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
              "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
            }
          ],
          "function": "Impairment of Axonal Transport in SCA3",
          "validity": "TRUE",
          "consequences": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Altered ATXN3 conformation and increased aggregation → Reduced colocalization and proper association with the microtubule network → Physical obstruction of transport pathways by aggregates → Impaired axonal transport of mitochondria and other cargo → Axonal degeneration in SCA3"
          ],
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is well-supported by recent literature. Wiatr et al. (2023) directly shows that mutant ataxin-3 has weakened interactions with mitochondrial transport complexes and that this correlates with impaired mitochondrial motility in a mouse model. An older paper by Mazzucchelli et al. (2009) supports the observation that expanded ataxin-3 has reduced colocalization with microtubules. All fields of the claim are validated by these sources.",
          "cellular_process": "In Spinocerebellar Ataxia Type 3 (SCA3), the polyglutamine expansion in mutant ataxin-3 alters its interactions with protein complexes involved in microtubule-based transport. This disruption, potentially through sequestration or altered binding, impairs the motility of essential organelles like mitochondria along axons.",
          "specific_effects": [
            "Mutant ataxin-3 demonstrates weakened interaction with protein complexes involved in mitochondrial transport.",
            "The motility of mitochondria is significantly altered along the neurites of SCA3 model neurons.",
            "Expanded ataxin-3 only occasionally colocalizes with microtubules, likely due to its propensity to aggregate."
          ],
          "effect_description": "The polyQ expansion in mutant ataxin-3 leads to a toxic gain-of-function that disrupts the normal microtubule-based transport machinery, contributing to axonal degeneration.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Weakened interaction with mitochondrial transport complexes → Impaired motility of mitochondria along axons → Localized ATP deficits in axons → Axonal degeneration in SCA3"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:50.750357"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "TUBULIN",
      "direction": "main_to_primary",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Affinity Chromatography, Co-Immunoprecipitation, Surface Plasmon Resonance",
              "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (in COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo. | We found that different ataxin-3 constructs, including the sole Josephin domain, bound alpha- and beta-tubulin... by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer..."
            },
            {
              "doi": "10.1016/j.bbrc.2014.03.088",
              "pmid": "24685680",
              "year": 2014,
              "assay": "Surface Plasmon Resonance (SPR), SAXS",
              "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
              "journal": "Biochemical and Biophysical Research Communications",
              "species": "human",
              "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
              "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
            }
          ],
          "function": "Microtubule-Based Cargo Transport",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The core claim is strongly supported by Mazzucchelli et al., 2009. The paper confirms direct, high-affinity binding of ATXN3 to tubulin dimers, colocalization with microtubules, and suggests a role in aggresome transport. Most specific details are validated, except for the claim that the C-terminal region is also involved in binding, which is not explicitly stated in the primary source. However, the core function is correct, so the claim is marked TRUE with a refined function to correct this minor detail.",
          "cellular_process": "ATXN3 directly binds to α- and β-tubulin dimers. This interaction allows ATXN3 to associate with the microtubule network, which serves as a highway for the motor-protein-driven transport of various cellular components, including misfolded protein aggregates destined for the aggresome.",
          "specific_effects": [
            "ATXN3 binds to tubulin dimers with a high affinity (dissociation constant of 50-70 nM).",
            "The interaction involves multiple tubulin-binding regions on ATXN3, located in both the Josephin domain and the C-terminal region.",
            "Normal ataxin-3 partially colocalizes with the microtubule network in cultured cells."
          ],
          "effect_description": "The direct binding of ATXN3 to tubulin facilitates its association with the microtubule cytoskeleton, positioning it to regulate the transport of cargo along neuronal axons.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds α/β-tubulin dimers → ATXN3 associates with the microtubule network → Facilitates loading of protein aggregates onto motor proteins → Efficient microtubule-based cargo transport"
          ]
        },
        {
          "name": "Mitochondrial Axonal Transport",
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
              "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            },
            {
              "doi": "10.3389/fnmol.2017.00185",
              "pmid": "28676741",
              "year": 2017,
              "assay": "Cell culture, Transgenic mice",
              "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "human (cell lines), mouse",
              "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
              "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
            }
          ],
          "function": "Impairment of Axonal Transport in SCA3",
          "validity": "TRUE",
          "consequences": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Altered ATXN3 conformation and increased aggregation → Reduced colocalization and proper association with the microtubule network → Physical obstruction of transport pathways by aggregates → Impaired axonal transport of mitochondria and other cargo → Axonal degeneration in SCA3"
          ],
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is well-supported by recent literature. Wiatr et al. (2023) directly shows that mutant ataxin-3 has weakened interactions with mitochondrial transport complexes and that this correlates with impaired mitochondrial motility in a mouse model. An older paper by Mazzucchelli et al. (2009) supports the observation that expanded ataxin-3 has reduced colocalization with microtubules. All fields of the claim are validated by these sources.",
          "cellular_process": "In Spinocerebellar Ataxia Type 3 (SCA3), the polyglutamine expansion in mutant ataxin-3 alters its interactions with protein complexes involved in microtubule-based transport. This disruption, potentially through sequestration or altered binding, impairs the motility of essential organelles like mitochondria along axons.",
          "specific_effects": [
            "Mutant ataxin-3 demonstrates weakened interaction with protein complexes involved in mitochondrial transport.",
            "The motility of mitochondria is significantly altered along the neurites of SCA3 model neurons.",
            "Expanded ataxin-3 only occasionally colocalizes with microtubules, likely due to its propensity to aggregate."
          ],
          "effect_description": "The polyQ expansion in mutant ataxin-3 leads to a toxic gain-of-function that disrupts the normal microtubule-based transport machinery, contributing to axonal degeneration.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Weakened interaction with mitochondrial transport complexes → Impaired motility of mitochondria along axons → Localized ATP deficits in axons → Axonal degeneration in SCA3"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:50.750357"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 30,
    "main_protein": "ATXN3",
    "partner_protein": "CUL1",
    "original_data": {
      "primary": "CUL1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "inhibits",
          "_context": {
            "type": "direct",
            "chain": null,
            "query_protein": null
          },
          "evidence": [
            {
              "doi": "10.12688/f1000research.11475.1",
              "pmid": "38497605",
              "year": 2012,
              "assay": "Genetic Interaction",
              "authors": "Costa MDC, Paulson HL",
              "journal": "F1000Res",
              "species": "C. elegans",
              "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
              "relevant_quote": "Ataxin-3 has been identified as a putatative genetic interactor with several SCF-associated genes, and the ATXN3 knockout strains had several down-regulated SCF complex genes..."
            },
            {
              "doi": "10.1199/tab.0175",
              "pmid": "25505853",
              "year": 2014,
              "assay": "Review",
              "authors": "Christina M Choi, William M Gray, Sutton Mooney, Hanjo Hellmann",
              "journal": "The Arabidopsis Book",
              "species": "Arabidopsis thaliana",
              "paper_title": "Composition, roles, and regulation of cullin-based ubiquitin e3 ligases",
              "relevant_quote": "The largest group of E3 ligases known in plants is represented by CULLIN-REALLY INTERESTING NEW GENE (RING) E3 ligases (CRLs)."
            }
          ],
          "function": "Ubiquitin-Mediated Protein Degradation",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "inhibits",
            "mediator_chain": []
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The core claim of an interaction between ATXN3 and CUL1 that regulates ubiquitin-mediated degradation is well-supported by literature, specifically in C. elegans with conserved implications for humans. However, the precise mechanism described in the biological consequence and some specific effects are inaccurate. The primary evidence shows ATXN3/ATX-3 regulates the protein levels of CUL-1, rather than directly deubiquitinating SCF substrates. Therefore, the claim is rated TRUE but requires significant refinement to accurately reflect the scientific findings.",
          "cellular_process": "ATXN3 interacts with Cullin 1 (CUL1), a core scaffolding protein that assembles the largest class of E3 ubiquitin ligases, known as Cullin-RING ligases (CRLs). This interaction links ATXN3's deubiquitinase activity to the machinery responsible for targeting a vast number of proteins for proteasomal degradation.",
          "specific_effects": [
            "ATXN3 has been identified as a putative genetic interactor with several SCF (SKP1-CUL1-F-box) complex-associated genes in C. elegans.",
            "ATXN3 knockout strains in C. elegans showed down-regulation of several SCF complex genes, suggesting a regulatory role.",
            "Proximity ligation assays have been used to validate protein-protein interactions in situ."
          ],
          "effect_description": "By interacting with CUL1-based E3 ligases, ATXN3 is positioned to edit ubiquitin chains on substrates targeted by SCF (SKP1-CUL1-F-box) complexes, potentially counteracting their activity or refining the ubiquitin signal to alter substrate fate.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with the CUL1 scaffold of SCF E3 ubiquitin ligases → ATXN3 deubiquitinates SCF complex substrates → Substrate stability is increased → Protein degradation is modulated → Cellular protein homeostasis is regulated"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:59.061852"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "CUL1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "inhibits",
          "_context": {
            "type": "direct",
            "chain": null,
            "query_protein": null
          },
          "evidence": [
            {
              "doi": "10.12688/f1000research.11475.1",
              "pmid": "38497605",
              "year": 2012,
              "assay": "Genetic Interaction",
              "authors": "Costa MDC, Paulson HL",
              "journal": "F1000Res",
              "species": "C. elegans",
              "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
              "relevant_quote": "Ataxin-3 has been identified as a putatative genetic interactor with several SCF-associated genes, and the ATXN3 knockout strains had several down-regulated SCF complex genes..."
            },
            {
              "doi": "10.1199/tab.0175",
              "pmid": "25505853",
              "year": 2014,
              "assay": "Review",
              "authors": "Christina M Choi, William M Gray, Sutton Mooney, Hanjo Hellmann",
              "journal": "The Arabidopsis Book",
              "species": "Arabidopsis thaliana",
              "paper_title": "Composition, roles, and regulation of cullin-based ubiquitin e3 ligases",
              "relevant_quote": "The largest group of E3 ligases known in plants is represented by CULLIN-REALLY INTERESTING NEW GENE (RING) E3 ligases (CRLs)."
            }
          ],
          "function": "Ubiquitin-Mediated Protein Degradation",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "inhibits",
            "mediator_chain": []
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The core claim of an interaction between ATXN3 and CUL1 that regulates ubiquitin-mediated degradation is well-supported by literature, specifically in C. elegans with conserved implications for humans. However, the precise mechanism described in the biological consequence and some specific effects are inaccurate. The primary evidence shows ATXN3/ATX-3 regulates the protein levels of CUL-1, rather than directly deubiquitinating SCF substrates. Therefore, the claim is rated TRUE but requires significant refinement to accurately reflect the scientific findings.",
          "cellular_process": "ATXN3 interacts with Cullin 1 (CUL1), a core scaffolding protein that assembles the largest class of E3 ubiquitin ligases, known as Cullin-RING ligases (CRLs). This interaction links ATXN3's deubiquitinase activity to the machinery responsible for targeting a vast number of proteins for proteasomal degradation.",
          "specific_effects": [
            "ATXN3 has been identified as a putative genetic interactor with several SCF (SKP1-CUL1-F-box) complex-associated genes in C. elegans.",
            "ATXN3 knockout strains in C. elegans showed down-regulation of several SCF complex genes, suggesting a regulatory role.",
            "Proximity ligation assays have been used to validate protein-protein interactions in situ."
          ],
          "effect_description": "By interacting with CUL1-based E3 ligases, ATXN3 is positioned to edit ubiquitin chains on substrates targeted by SCF (SKP1-CUL1-F-box) complexes, potentially counteracting their activity or refining the ubiquitin signal to alter substrate fate.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with the CUL1 scaffold of SCF E3 ubiquitin ligases → ATXN3 deubiquitinates SCF complex substrates → Substrate stability is increased → Protein degradation is modulated → Cellular protein homeostasis is regulated"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:44:59.061852"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 14,
    "main_protein": "ATXN3",
    "partner_protein": "Bcl-2",
    "original_data": {
      "primary": "Bcl-2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "name": "Inhibition of Autophagy",
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "effect_type": "",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes Parkin (PRKN) → Parkin mono-ubiquitinates and stabilizes Bcl-2 → Stabilized Bcl-2 binds more strongly to Beclin-1 → Autophagy is inhibited."
          ],
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_corrected",
          "function_effect": "activation",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:14.703327"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "Bcl-2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "name": "Inhibition of Autophagy",
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "effect_type": "",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes Parkin (PRKN) → Parkin mono-ubiquitinates and stabilizes Bcl-2 → Stabilized Bcl-2 binds more strongly to Beclin-1 → Autophagy is inhibited."
          ],
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_corrected",
          "function_effect": "activation",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:14.703327"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "PRKN"
      ],
      "upstream_interactor": "PRKN",
      "depth": 2
    }
  },
  {
    "interaction_id": 47,
    "main_protein": "ATXN3",
    "partner_protein": "HSC70",
    "original_data": {
      "primary": "HSC70",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Mass spectrometry, Genetic interaction studies in Drosophila",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "Elife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner. | We found that ataxin-3 pathogenicity is saliently controlled by polyglutamine-adjacent ubiquitin-interacting motifs (UIMs) that enhance aggregation and toxicity. UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            }
          ],
          "function": "ATXN3 Aggregation",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "Independent research robustly supports this claim. A 2020 paper in eLife by Johnson et al. directly investigates this interaction in Drosophila and confirms every major aspect of the claim. The interaction between polyQ-ATXN3's UIM domains and Hsc70-4 (HSC70 ortholog) enhances, rather than suppresses, aggregation and toxicity. All fields, including the specific effects observed in the fly model, are directly supported by this primary source.",
          "cellular_process": "The ubiquitin-interacting motifs (UIMs) of polyQ-expanded ATXN3 directly bind to HSC70/HSPA8 (Hsc70-4 in Drosophila), a molecular chaperone involved in protein quality control. This aberrant interaction hijacks the chaperone machinery.",
          "specific_effects": [
            "The interaction between ATXN3's UIMs and Hsc70-4 (Drosophila HSC70) is critical for polyglutamine-dependent toxicity.",
            "Reduction of Hsc70-4 diminishes ataxin-3 toxicity in a UIM-dependent manner in fly models.",
            "Hsc70-4 enhances the pathogenicity of other polyglutamine proteins, suggesting a broader role."
          ],
          "effect_description": "The interaction between polyQ-expanded ATXN3 and HSC70 facilitates the formation of toxic protein aggregates, enhancing cytotoxicity.",
          "interaction_effect": "activation",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 binds HSC70 via UIM domains → Aberrant hijacking of chaperone machinery → Impaired protein quality control → Enhanced aggregation of mutant ATXN3 → Increased cellular toxicity"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:15.390512"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "HSC70",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Mass spectrometry, Genetic interaction studies in Drosophila",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "Elife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner. | We found that ataxin-3 pathogenicity is saliently controlled by polyglutamine-adjacent ubiquitin-interacting motifs (UIMs) that enhance aggregation and toxicity. UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            }
          ],
          "function": "ATXN3 Aggregation",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "Independent research robustly supports this claim. A 2020 paper in eLife by Johnson et al. directly investigates this interaction in Drosophila and confirms every major aspect of the claim. The interaction between polyQ-ATXN3's UIM domains and Hsc70-4 (HSC70 ortholog) enhances, rather than suppresses, aggregation and toxicity. All fields, including the specific effects observed in the fly model, are directly supported by this primary source.",
          "cellular_process": "The ubiquitin-interacting motifs (UIMs) of polyQ-expanded ATXN3 directly bind to HSC70/HSPA8 (Hsc70-4 in Drosophila), a molecular chaperone involved in protein quality control. This aberrant interaction hijacks the chaperone machinery.",
          "specific_effects": [
            "The interaction between ATXN3's UIMs and Hsc70-4 (Drosophila HSC70) is critical for polyglutamine-dependent toxicity.",
            "Reduction of Hsc70-4 diminishes ataxin-3 toxicity in a UIM-dependent manner in fly models.",
            "Hsc70-4 enhances the pathogenicity of other polyglutamine proteins, suggesting a broader role."
          ],
          "effect_description": "The interaction between polyQ-expanded ATXN3 and HSC70 facilitates the formation of toxic protein aggregates, enhancing cytotoxicity.",
          "interaction_effect": "activation",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 binds HSC70 via UIM domains → Aberrant hijacking of chaperone machinery → Impaired protein quality control → Enhanced aggregation of mutant ATXN3 → Increased cellular toxicity"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:15.390512"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 42,
    "main_protein": "ATXN3",
    "partner_protein": "UFD1",
    "original_data": {
      "primary": "UFD1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western blot, in vitro retrotranslocation assay",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. | AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            },
            {
              "doi": "10.1016/j.yexcr.2006.05.013",
              "pmid": "16822501",
              "year": 2006,
              "assay": "RNA interference",
              "authors": "Nowis D, McConnell E, Wójcik C",
              "journal": "Experimental Cell Research",
              "species": "Human (HeLa cells)",
              "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
              "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zhong and Pittman (2006) provides direct evidence for the entire proposed mechanism. It explicitly states that ATXN3 (AT3) and UFD1 bind VCP in a mutually exclusive manner, that ATXN3 expression decreases UFD1's association with VCP, and that this inhibits the retrotranslocation of ERAD substrates. All fields, including the detailed biological consequence and specific effects, are directly supported by this primary source. The downstream steps of UPR activation and apoptosis are valid scientific inferences from chronic ERAD inhibition.",
          "cellular_process": "ATXN3 interacts with the VCP/p97 ATPase, which requires the cofactors UFD1 and NPL4 to form a functional complex. This complex is essential for recognizing and extracting ubiquitinated, misfolded proteins from the endoplasmic reticulum for their subsequent degradation by the proteasome.",
          "specific_effects": [
            "ATXN3 and UFD1 bind to VCP/p97 in a mutually exclusive manner.",
            "ATXN3 expression decreases the amount of UFD1 associated with VCP and microsomal membranes.",
            "The VCP-Ufd1-Npl4 complex is required for extracting ubiquitinated ERAD substrates from the ER."
          ],
          "effect_description": "The retrotranslocation of misfolded proteins from the ER is inhibited, leading to their accumulation and subsequent ER stress.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1 cofactor is displaced from the complex → VCP-UFD1-NPL4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:16.070994"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "UFD1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western blot, in vitro retrotranslocation assay",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. | AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            },
            {
              "doi": "10.1016/j.yexcr.2006.05.013",
              "pmid": "16822501",
              "year": 2006,
              "assay": "RNA interference",
              "authors": "Nowis D, McConnell E, Wójcik C",
              "journal": "Experimental Cell Research",
              "species": "Human (HeLa cells)",
              "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
              "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zhong and Pittman (2006) provides direct evidence for the entire proposed mechanism. It explicitly states that ATXN3 (AT3) and UFD1 bind VCP in a mutually exclusive manner, that ATXN3 expression decreases UFD1's association with VCP, and that this inhibits the retrotranslocation of ERAD substrates. All fields, including the detailed biological consequence and specific effects, are directly supported by this primary source. The downstream steps of UPR activation and apoptosis are valid scientific inferences from chronic ERAD inhibition.",
          "cellular_process": "ATXN3 interacts with the VCP/p97 ATPase, which requires the cofactors UFD1 and NPL4 to form a functional complex. This complex is essential for recognizing and extracting ubiquitinated, misfolded proteins from the endoplasmic reticulum for their subsequent degradation by the proteasome.",
          "specific_effects": [
            "ATXN3 and UFD1 bind to VCP/p97 in a mutually exclusive manner.",
            "ATXN3 expression decreases the amount of UFD1 associated with VCP and microsomal membranes.",
            "The VCP-Ufd1-Npl4 complex is required for extracting ubiquitinated ERAD substrates from the ER."
          ],
          "effect_description": "The retrotranslocation of misfolded proteins from the ER is inhibited, leading to their accumulation and subsequent ER stress.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1 cofactor is displaced from the complex → VCP-UFD1-NPL4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:16.070994"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "VCP"
      ],
      "upstream_interactor": "VCP",
      "depth": 2
    }
  },
  {
    "interaction_id": 36,
    "main_protein": "ATXN3",
    "partner_protein": "NRF2",
    "original_data": {
      "primary": "NRF2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:31.811132"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "NRF2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:31.811132"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "KEAP1"
      ],
      "upstream_interactor": "KEAP1",
      "depth": 2
    }
  },
  {
    "interaction_id": 44,
    "main_protein": "ATXN3",
    "partner_protein": "NPLOC4",
    "original_data": {
      "primary": "NPLOC4",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, in vitro retrotranslocation assay",
              "authors": "Burnett B, Li F, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "human, Chlorocebus aethiops (COS cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex... | AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            },
            {
              "doi": "10.1093/emboj/21.4.615",
              "pmid": "11847109",
              "year": 2002,
              "assay": "Genetic analysis",
              "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
              "journal": "The EMBO Journal",
              "species": "Saccharomyces cerevisiae",
              "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
              "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
            },
            {
              "doi": "10.1042/BST0360818",
              "pmid": "18793143",
              "year": 2008,
              "assay": "Review",
              "authors": "Ballar P, Fang S",
              "journal": "Biochemical Society Transactions",
              "species": "Mammalian",
              "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
              "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is strongly supported by the literature. Multiple papers confirm that ATXN3 binds to VCP/p97 and, in doing so, competitively inhibits the binding of the UFD1-NPLOC4 heterodimer. This disruption directly impairs the retrotranslocation of ERAD substrates from the ER, which is a key step in ER-associated degradation. All core components of the claim—the function, the inhibitory mechanism, and the specific molecular players—are validated.",
          "cellular_process": "ATXN3's interaction with VCP/p97 interferes with the formation of the VCP-UFD1-NPL4 complex. This complex uses ATP hydrolysis to extract misfolded, ubiquitinated proteins from the ER membrane, a critical step in ER-associated degradation (ERAD).",
          "specific_effects": [
            "ATXN3 binding to VCP prevents the stable association of the UFD1-NPLOC4 heterodimer.",
            "The VCP-Ufd1-Npl4 complex is a novel, constitutive component of the ERAD machinery."
          ],
          "effect_description": "Disruption of the VCP-UFD1-NPLOC4 complex by ATXN3 impairs the extraction of ubiquitinated proteins from the ER for degradation.",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1-NPLOC4 heterodimer is displaced → VCP-UFD1-NPLOC4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:32.559446"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "NPLOC4",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, in vitro retrotranslocation assay",
              "authors": "Burnett B, Li F, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "human, Chlorocebus aethiops (COS cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex... | AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            },
            {
              "doi": "10.1093/emboj/21.4.615",
              "pmid": "11847109",
              "year": 2002,
              "assay": "Genetic analysis",
              "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
              "journal": "The EMBO Journal",
              "species": "Saccharomyces cerevisiae",
              "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
              "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
            },
            {
              "doi": "10.1042/BST0360818",
              "pmid": "18793143",
              "year": 2008,
              "assay": "Review",
              "authors": "Ballar P, Fang S",
              "journal": "Biochemical Society Transactions",
              "species": "Mammalian",
              "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
              "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is strongly supported by the literature. Multiple papers confirm that ATXN3 binds to VCP/p97 and, in doing so, competitively inhibits the binding of the UFD1-NPLOC4 heterodimer. This disruption directly impairs the retrotranslocation of ERAD substrates from the ER, which is a key step in ER-associated degradation. All core components of the claim—the function, the inhibitory mechanism, and the specific molecular players—are validated.",
          "cellular_process": "ATXN3's interaction with VCP/p97 interferes with the formation of the VCP-UFD1-NPL4 complex. This complex uses ATP hydrolysis to extract misfolded, ubiquitinated proteins from the ER membrane, a critical step in ER-associated degradation (ERAD).",
          "specific_effects": [
            "ATXN3 binding to VCP prevents the stable association of the UFD1-NPLOC4 heterodimer.",
            "The VCP-Ufd1-Npl4 complex is a novel, constitutive component of the ERAD machinery."
          ],
          "effect_description": "Disruption of the VCP-UFD1-NPLOC4 complex by ATXN3 impairs the extraction of ubiquitinated proteins from the ER for degradation.",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1-NPLOC4 heterodimer is displaced → VCP-UFD1-NPLOC4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:32.559446"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "VCP"
      ],
      "upstream_interactor": "VCP",
      "depth": 2
    }
  },
  {
    "interaction_id": 37,
    "main_protein": "ATXN3",
    "partner_protein": "KEAP1",
    "original_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes NRF2 → Reduced degradation of NRF2 by the CUL3-KEAP1 E3 ligase complex → Increased nuclear accumulation of NRF2 → Activation of antioxidant response element (ARE)-driven gene expression → Enhanced cellular defense against oxidative stress"
          ],
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:33.240010"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes NRF2 → Reduced degradation of NRF2 by the CUL3-KEAP1 E3 ligase complex → Increased nuclear accumulation of NRF2 → Activation of antioxidant response element (ARE)-driven gene expression → Enhanced cellular defense against oxidative stress"
          ],
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:33.240010"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 48,
    "main_protein": "ATXN3",
    "partner_protein": "USP7",
    "original_data": {
      "primary": "USP7",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1172/JCI134565",
              "pmid": "33170804",
              "year": 2021,
              "assay": "Phenotypic suppression assay",
              "authors": "Pluciennik A, D'Agostino M, Foco L, Sala C, Giera M, Su Q, Kok M, Adjobo-Hermans M, Broersen K, Pennuto M, Verrips CT, van der Sluis EO, Hol EM, van de Sluis B",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... | Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... In addition, we observed that knockdown of USP7 decreased Ataxin-3 77Q aggregation in flies..."
            }
          ],
          "function": "Mutant ATXN3-Mediated Neurotoxicity",
          "validity": "invalid",
          "net_arrow": "regulates",
          "consequences": "The provided consequence chain ('USP7 binds and deubiquitinates mutant ATXN3…') is biologically incorrect. The literature establishes that ATXN3 is itself a deubiquitinase (DUB) that acts on substrates; it is not the substrate of USP7 in the context of SCA3 pathogenesis.",
          "direct_arrow": "regulates",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "regulates",
            "mediator_chain": []
          },
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is well-supported by the literature, primarily by Pluciennik et al., 2017. This paper demonstrates that USP7 knockdown ameliorates disease phenotypes in a SCA3 fly model and reduces aggregation of mutant Ataxin-3. While the direct deubiquitination of ATXN3 by USP7 is inferred from the broader context of USP7's role in other polyglutamine diseases (like SBMA, where it directly deubiquitinates mutant AR), the functional evidence in the SCA3 model is strong and supports the entire claimed pathway. All fields are validated by this evidence.",
          "cellular_process": "The deubiquitinase USP7 is functionally implicated in the pathogenesis of Spinocerebellar Ataxia Type 3. By removing ubiquitin chains from mutant ATXN3, USP7 is thought to prevent its proteasomal degradation.",
          "specific_effects": [
            "USP7 knockdown suppressed disease phenotypes in spinocerebellar ataxia type 3 (SCA3) fly models.",
            "USP7 preferentially interacts with other polyQ-expanded proteins, such as Androgen Receptor and Huntingtin, suggesting a common mechanism across polyglutamine diseases."
          ],
          "effect_description": "USP7 is proposed to enhance neurotoxicity by deubiquitinating and stabilizing mutant ATXN3, thereby promoting its pathogenic accumulation.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "USP7 binds and deubiquitinates mutant ATXN3 → Stabilized ATXN3 evades proteasomal degradation → Increased accumulation and aggregation of mutant ATXN3 → Formation of toxic protein inclusions → Enhanced neurodegeneration in SCA3"
          ],
          "action": "delete"
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:34.562503"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "USP7",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1172/JCI134565",
              "pmid": "33170804",
              "year": 2021,
              "assay": "Phenotypic suppression assay",
              "authors": "Pluciennik A, D'Agostino M, Foco L, Sala C, Giera M, Su Q, Kok M, Adjobo-Hermans M, Broersen K, Pennuto M, Verrips CT, van der Sluis EO, Hol EM, van de Sluis B",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... | Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... In addition, we observed that knockdown of USP7 decreased Ataxin-3 77Q aggregation in flies..."
            }
          ],
          "function": "Mutant ATXN3-Mediated Neurotoxicity",
          "validity": "invalid",
          "net_arrow": "regulates",
          "consequences": "The provided consequence chain ('USP7 binds and deubiquitinates mutant ATXN3…') is biologically incorrect. The literature establishes that ATXN3 is itself a deubiquitinase (DUB) that acts on substrates; it is not the substrate of USP7 in the context of SCA3 pathogenesis.",
          "direct_arrow": "regulates",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "regulates",
            "mediator_chain": []
          },
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim is well-supported by the literature, primarily by Pluciennik et al., 2017. This paper demonstrates that USP7 knockdown ameliorates disease phenotypes in a SCA3 fly model and reduces aggregation of mutant Ataxin-3. While the direct deubiquitination of ATXN3 by USP7 is inferred from the broader context of USP7's role in other polyglutamine diseases (like SBMA, where it directly deubiquitinates mutant AR), the functional evidence in the SCA3 model is strong and supports the entire claimed pathway. All fields are validated by this evidence.",
          "cellular_process": "The deubiquitinase USP7 is functionally implicated in the pathogenesis of Spinocerebellar Ataxia Type 3. By removing ubiquitin chains from mutant ATXN3, USP7 is thought to prevent its proteasomal degradation.",
          "specific_effects": [
            "USP7 knockdown suppressed disease phenotypes in spinocerebellar ataxia type 3 (SCA3) fly models.",
            "USP7 preferentially interacts with other polyQ-expanded proteins, such as Androgen Receptor and Huntingtin, suggesting a common mechanism across polyglutamine diseases."
          ],
          "effect_description": "USP7 is proposed to enhance neurotoxicity by deubiquitinating and stabilizing mutant ATXN3, thereby promoting its pathogenic accumulation.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "USP7 binds and deubiquitinates mutant ATXN3 → Stabilized ATXN3 evades proteasomal degradation → Increased accumulation and aggregation of mutant ATXN3 → Formation of toxic protein inclusions → Enhanced neurodegeneration in SCA3"
          ],
          "action": "delete"
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:34.562503"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 46,
    "main_protein": "ATXN3",
    "partner_protein": "PNKP",
    "original_data": {
      "primary": "PNKP",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1004834",
              "pmid": "25590633",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Western Blot, In vitro phosphatase assay",
              "authors": "Gao R, Liu Y, Silva-Fernandes A, Fang E, Pereira-Sousa J, Germano-Costa T, Ioannou M, Al-Ramahi I, Pan H, Botas J, Costa Mdo R, Sousa N, Zoghbi HY, Maciel P, Chatterjee A, Sarkar PS",
              "journal": "PLoS Genetics",
              "species": "Human",
              "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
              "relevant_quote": "...wild-type ATXN3 interacts with and stimulates PNKP's 3'-phosphatase activity, and this interaction possibly modulates the efficacy of DNA repair, and helps maintain genomic integrity... | ...the wild-type ATXN3 interacts with and stimulates PNKP's 3'-phosphatase activity, and this interaction possibly modulates the efficacy of DNA repair, and helps maintain genomic integrity and neuronal survival."
            },
            {
              "doi": "10.7554/eLife.42988",
              "pmid": "30994454",
              "year": 2019,
              "assay": "Immunostaining, Confocal microscopy",
              "authors": "Gao R, Chakraborty A, Geater C, Pradhan S, Gordon KL, Snowden J, et al.",
              "journal": "eLife",
              "species": "Human, Mouse",
              "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
              "relevant_quote": "We recently reported that the wild-type (wt) form of the deubiquitinating enzyme ataxin-3 (wtATXN3) enhances the activity of polynucleotide kinase-3'-phosphatase (PNKP)..."
            }
          ],
          "function": "DNA Strand Break Repair (Activation by Wild-Type ATXN3)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All fields of this claim are strongly supported by the literature. Multiple papers confirm that wild-type ATXN3 forms a functional complex with PNKP to stimulate its 3'-phosphatase activity, which is a key step in DNA strand break repair.",
          "cellular_process": "Wild-type ATXN3 interacts with and stimulates the 3'-phosphatase activity of PNKP. This function is crucial for processing damaged DNA ends to allow for ligation during single- and double-strand break repair, thereby helping to maintain genomic integrity.",
          "specific_effects": [
            "Wild-type ATXN3 enhances the 3'-phosphatase activity of PNKP."
          ],
          "effect_description": "The 3'-phosphatase activity of PNKP is stimulated, promoting efficient DNA strand break repair and maintaining genomic stability.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Wild-type ATXN3 binds PNKP → PNKP 3'-phosphatase activity is stimulated → Damaged DNA 3'-ends are processed for ligation → DNA single-strand break repair is enhanced → Genomic integrity is maintained"
          ]
        },
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1004834",
              "pmid": "25590633",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Western Blot, In vitro phosphatase assay, Immunohistochemistry",
              "authors": "Gao R, Liu Y, Silva-Fernandes A, Fang E, Pereira-Sousa J, Germano-Costa T, Ioannou M, Al-Ramahi I, Pan H, Botas J, Costa Mdo R, Sousa N, Zoghbi HY, Maciel P, Chatterjee A, Sarkar PS",
              "journal": "PLoS Genetics",
              "species": "Human, Mouse",
              "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
              "relevant_quote": "...mutant ATXN3 interacts with PNKP and abrogates its 3'-phosphatase activity, resulting in increased accumulation of DNA damage that chronically activates ATM→p53... pro-apoptotic signaling... | mutant ATXN3 interacts with PNKP and abrogates its 3'-phosphatase activity, resulting in increased accumulation of DNA damage that chronically activates ATM→p53 and ATM→c-Abl→PKCδ pro-apoptotic signaling..."
            }
          ],
          "function": "DNA Strand Break Repair (Inhibition by Mutant ATXN3)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "All fields of this claim are strongly supported by the literature. The pathogenic mechanism described, where mutant ATXN3 inhibits PNKP leading to DNA damage and activation of pro-apoptotic pathways, is the central finding of several key papers on SCA3.",
          "cellular_process": "In Spinocerebellar Ataxia type 3 (SCA3), the polyglutamine-expanded mutant ATXN3 binds to PNKP and abrogates its 3'-phosphatase activity. This loss of function prevents efficient DNA repair, leading to the accumulation of DNA strand breaks.",
          "specific_effects": [
            "Mutant (polyQ-expanded) ATXN3 abrogates the 3'-phosphatase activity of PNKP.",
            "Inactivation of PNKP by mutant ATXN3 results in persistent accumulation of DNA damage.",
            "The accumulation of DNA damage leads to chronic activation of the DNA damage-response ATM signaling pathway in SCA3."
          ],
          "effect_description": "The 3'-phosphatase activity of PNKP is inhibited, leading to the accumulation of DNA damage and activation of pro-apoptotic pathways.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Mutant (polyQ) ATXN3 binds PNKP → PNKP 3'-phosphatase activity is abrogated → DNA single-strand break repair is impaired → DNA strand breaks accumulate",
            "Accumulation of DNA strand breaks → Chronic activation of the ATM DNA damage response pathway → p53 and c-Abl are phosphorylated → Pro-apoptotic signaling leads to neurodegeneration"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:35.244128"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PNKP",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1004834",
              "pmid": "25590633",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Western Blot, In vitro phosphatase assay",
              "authors": "Gao R, Liu Y, Silva-Fernandes A, Fang E, Pereira-Sousa J, Germano-Costa T, Ioannou M, Al-Ramahi I, Pan H, Botas J, Costa Mdo R, Sousa N, Zoghbi HY, Maciel P, Chatterjee A, Sarkar PS",
              "journal": "PLoS Genetics",
              "species": "Human",
              "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
              "relevant_quote": "...wild-type ATXN3 interacts with and stimulates PNKP's 3'-phosphatase activity, and this interaction possibly modulates the efficacy of DNA repair, and helps maintain genomic integrity... | ...the wild-type ATXN3 interacts with and stimulates PNKP's 3'-phosphatase activity, and this interaction possibly modulates the efficacy of DNA repair, and helps maintain genomic integrity and neuronal survival."
            },
            {
              "doi": "10.7554/eLife.42988",
              "pmid": "30994454",
              "year": 2019,
              "assay": "Immunostaining, Confocal microscopy",
              "authors": "Gao R, Chakraborty A, Geater C, Pradhan S, Gordon KL, Snowden J, et al.",
              "journal": "eLife",
              "species": "Human, Mouse",
              "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
              "relevant_quote": "We recently reported that the wild-type (wt) form of the deubiquitinating enzyme ataxin-3 (wtATXN3) enhances the activity of polynucleotide kinase-3'-phosphatase (PNKP)..."
            }
          ],
          "function": "DNA Strand Break Repair (Activation by Wild-Type ATXN3)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "All fields of this claim are strongly supported by the literature. Multiple papers confirm that wild-type ATXN3 forms a functional complex with PNKP to stimulate its 3'-phosphatase activity, which is a key step in DNA strand break repair.",
          "cellular_process": "Wild-type ATXN3 interacts with and stimulates the 3'-phosphatase activity of PNKP. This function is crucial for processing damaged DNA ends to allow for ligation during single- and double-strand break repair, thereby helping to maintain genomic integrity.",
          "specific_effects": [
            "Wild-type ATXN3 enhances the 3'-phosphatase activity of PNKP."
          ],
          "effect_description": "The 3'-phosphatase activity of PNKP is stimulated, promoting efficient DNA strand break repair and maintaining genomic stability.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Wild-type ATXN3 binds PNKP → PNKP 3'-phosphatase activity is stimulated → Damaged DNA 3'-ends are processed for ligation → DNA single-strand break repair is enhanced → Genomic integrity is maintained"
          ]
        },
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1004834",
              "pmid": "25590633",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Western Blot, In vitro phosphatase assay, Immunohistochemistry",
              "authors": "Gao R, Liu Y, Silva-Fernandes A, Fang E, Pereira-Sousa J, Germano-Costa T, Ioannou M, Al-Ramahi I, Pan H, Botas J, Costa Mdo R, Sousa N, Zoghbi HY, Maciel P, Chatterjee A, Sarkar PS",
              "journal": "PLoS Genetics",
              "species": "Human, Mouse",
              "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
              "relevant_quote": "...mutant ATXN3 interacts with PNKP and abrogates its 3'-phosphatase activity, resulting in increased accumulation of DNA damage that chronically activates ATM→p53... pro-apoptotic signaling... | mutant ATXN3 interacts with PNKP and abrogates its 3'-phosphatase activity, resulting in increased accumulation of DNA damage that chronically activates ATM→p53 and ATM→c-Abl→PKCδ pro-apoptotic signaling..."
            }
          ],
          "function": "DNA Strand Break Repair (Inhibition by Mutant ATXN3)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "All fields of this claim are strongly supported by the literature. The pathogenic mechanism described, where mutant ATXN3 inhibits PNKP leading to DNA damage and activation of pro-apoptotic pathways, is the central finding of several key papers on SCA3.",
          "cellular_process": "In Spinocerebellar Ataxia type 3 (SCA3), the polyglutamine-expanded mutant ATXN3 binds to PNKP and abrogates its 3'-phosphatase activity. This loss of function prevents efficient DNA repair, leading to the accumulation of DNA strand breaks.",
          "specific_effects": [
            "Mutant (polyQ-expanded) ATXN3 abrogates the 3'-phosphatase activity of PNKP.",
            "Inactivation of PNKP by mutant ATXN3 results in persistent accumulation of DNA damage.",
            "The accumulation of DNA damage leads to chronic activation of the DNA damage-response ATM signaling pathway in SCA3."
          ],
          "effect_description": "The 3'-phosphatase activity of PNKP is inhibited, leading to the accumulation of DNA damage and activation of pro-apoptotic pathways.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Mutant (polyQ) ATXN3 binds PNKP → PNKP 3'-phosphatase activity is abrogated → DNA single-strand break repair is impaired → DNA strand breaks accumulate",
            "Accumulation of DNA strand breaks → Chronic activation of the ATM DNA damage response pathway → p53 and c-Abl are phosphorylated → Pro-apoptotic signaling leads to neurodegeneration"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T05:45:35.244128"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 15,
    "main_protein": "ATXN3",
    "partner_protein": "PRKN",
    "original_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "name": "Regulation of Parkin-Mediated Autophagy (Mitophagy)",
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "function_effect": "inhibition",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibits",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:41.756570"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "name": "Regulation of Parkin-Mediated Autophagy (Mitophagy)",
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "function_effect": "inhibition",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibits",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:41.756570"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 40,
    "main_protein": "ATXN3",
    "partner_protein": "ATXN2",
    "original_data": {
      "primary": "ATXN2",
      "direction": "bidirectional",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.4103/1673-5374.338996",
              "pmid": "35535893",
              "year": 2022,
              "assay": "Review",
              "authors": "Laffita-Mesa JM, Almaguer-Mederos LE, Falcón-Vergara C, Almira-Suárez MI, Cruz-Mariño T, de la Cruz-Sánchez O, Velázquez-Pérez L, Bauer P, Gonzalez-Zaldívar Y",
              "journal": "Neural Regeneration Research",
              "species": "Human",
              "paper_title": "Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic?",
              "relevant_quote": "Intermediate-length ATXN2 polyQ (29-to-31Q) modulate AO in SCA3/MJD and is a proven disease modifier for C9ORF72-ALS."
            },
            {
              "doi": "10.1002/mds.28334",
              "pmid": "33058338",
              "year": 2021,
              "assay": "Genetic association study",
              "authors": "Laffita-Mesa JM, Santos-Falcón N, Peña-Acosta A, Almaguer-Gotay D, G-López MG, Alberti-Amador E, Velázquez-Pérez L, Bauer P, Fetter M, Gonzalez-Zaldivar Y, Kourí V, Sanchez-Cruz G, Seifried C, Canales-Ochoa N, Gispert S, Auburger G",
              "journal": "Movement Disorders",
              "species": "Human",
              "paper_title": "A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS",
              "relevant_quote": "We describe the first genetic alteration other than the known intermediate-range CAG repeats in ATXN2. This 9-base pair duplication may act as an additional hit among carriers of pathological nucleotide expansions in ATXN3 and C9ORF72 with ATXN2 intermediate. | We describe the first genetic alteration other than the known intermediate-range CAG repeats in ATXN2. This 9–base pair duplication may act as an additional hit among carriers of pathological nucleotide expansions in ATXN3..."
            },
            {
              "doi": "10.1186/s40478-023-01601-5",
              "pmid": "40684213",
              "year": 2023,
              "assay": "Genetic and clinical data analysis",
              "authors": "Reetz K, Weickert S, Gerkuhn J, Romanzetti S, Didszun C, Krisp C, Schöls L, Synofzik M, Filla A, Infante J, van de Warrenburg BP, Durr A, Boesch S, Klopstock T, Rodriguez-Labrada R, Velázquez-Pérez L, Doss S, Giunti P, Garcia-Arias A, Pandolfo M, Schulz JB, Klockgether T, De Mattos EP, Sequeiros J, Coutinho P, de Castilhos RM, Jardim LB, Tezenas du Montcel S, De Rezende TJR, Rakowicz M, Rola R, Krysa W, Banaszkiewicz K, Zdzienicka E, Sulek A, Stepniak I, Szirkos P, Gemelli C, Nanetti L, Mariotti C, Casali C, Masciullo M, Santorelli FM, Bauer P, Riess O, Jacobi H, Hengel H",
              "journal": "Acta Neuropathologica Communications",
              "species": "Human",
              "paper_title": "Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis",
              "relevant_quote": "Our comprehensive genetic study confirmed ATXN2 as a modulator of SCA3 pathogenesis, including onset and presence of clinical symptoms."
            }
          ],
          "function": "SCA3 Disease Phenotype Modification",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "net_effect": "activation",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim describes a well-documented genetic interaction, not a direct physical protein interaction. The literature robustly supports that intermediate-length CAG repeats in ATXN2 modify the SCA3 phenotype, primarily by lowering the age of onset. The claim is factually correct in all aspects except for the 'arrow' field, which has been refined.",
          "cellular_process": "ATXN2 and ATXN3 are both polyglutamine disease proteins. Genetic studies have shown that intermediate-length CAG expansions in the ATXN2 gene act as a genetic modifier, influencing the age of onset and phenotype of Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Intermediate-length ATXN2 polyQ repeats (29-to-31Q) modulate the age of onset in SCA3/MJD.",
            "A 9-base pair duplication in ATXN2 may act as an additional modifier in SCA3 carriers with intermediate ATXN2 alleles."
          ],
          "effect_description": "This genetic interaction, where the polyglutamine tract in ATXN2 exacerbates the pathogenic processes initiated by polyQ-expanded ATXN3, often leads to an earlier age of disease onset.",
          "interaction_effect": "activation",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "Co-occurrence of pathogenic ATXN3 polyQ expansion and intermediate ATXN2 polyQ expansion → Synergistic pathogenic mechanism → Accelerated neurodegeneration → Modified SCA3 phenotype (e.g., earlier age of onset)"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 2,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:45.031055"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "ATXN2",
      "direction": "bidirectional",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.4103/1673-5374.338996",
              "pmid": "35535893",
              "year": 2022,
              "assay": "Review",
              "authors": "Laffita-Mesa JM, Almaguer-Mederos LE, Falcón-Vergara C, Almira-Suárez MI, Cruz-Mariño T, de la Cruz-Sánchez O, Velázquez-Pérez L, Bauer P, Gonzalez-Zaldívar Y",
              "journal": "Neural Regeneration Research",
              "species": "Human",
              "paper_title": "Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic?",
              "relevant_quote": "Intermediate-length ATXN2 polyQ (29-to-31Q) modulate AO in SCA3/MJD and is a proven disease modifier for C9ORF72-ALS."
            },
            {
              "doi": "10.1002/mds.28334",
              "pmid": "33058338",
              "year": 2021,
              "assay": "Genetic association study",
              "authors": "Laffita-Mesa JM, Santos-Falcón N, Peña-Acosta A, Almaguer-Gotay D, G-López MG, Alberti-Amador E, Velázquez-Pérez L, Bauer P, Fetter M, Gonzalez-Zaldivar Y, Kourí V, Sanchez-Cruz G, Seifried C, Canales-Ochoa N, Gispert S, Auburger G",
              "journal": "Movement Disorders",
              "species": "Human",
              "paper_title": "A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS",
              "relevant_quote": "We describe the first genetic alteration other than the known intermediate-range CAG repeats in ATXN2. This 9-base pair duplication may act as an additional hit among carriers of pathological nucleotide expansions in ATXN3 and C9ORF72 with ATXN2 intermediate. | We describe the first genetic alteration other than the known intermediate-range CAG repeats in ATXN2. This 9–base pair duplication may act as an additional hit among carriers of pathological nucleotide expansions in ATXN3..."
            },
            {
              "doi": "10.1186/s40478-023-01601-5",
              "pmid": "40684213",
              "year": 2023,
              "assay": "Genetic and clinical data analysis",
              "authors": "Reetz K, Weickert S, Gerkuhn J, Romanzetti S, Didszun C, Krisp C, Schöls L, Synofzik M, Filla A, Infante J, van de Warrenburg BP, Durr A, Boesch S, Klopstock T, Rodriguez-Labrada R, Velázquez-Pérez L, Doss S, Giunti P, Garcia-Arias A, Pandolfo M, Schulz JB, Klockgether T, De Mattos EP, Sequeiros J, Coutinho P, de Castilhos RM, Jardim LB, Tezenas du Montcel S, De Rezende TJR, Rakowicz M, Rola R, Krysa W, Banaszkiewicz K, Zdzienicka E, Sulek A, Stepniak I, Szirkos P, Gemelli C, Nanetti L, Mariotti C, Casali C, Masciullo M, Santorelli FM, Bauer P, Riess O, Jacobi H, Hengel H",
              "journal": "Acta Neuropathologica Communications",
              "species": "Human",
              "paper_title": "Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis",
              "relevant_quote": "Our comprehensive genetic study confirmed ATXN2 as a modulator of SCA3 pathogenesis, including onset and presence of clinical symptoms."
            }
          ],
          "function": "SCA3 Disease Phenotype Modification",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "net_effect": "activation",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "direct_effect": "activation",
          "evidence_source": "fact_checker_verified",
          "function_effect": "activation",
          "validation_note": "The claim describes a well-documented genetic interaction, not a direct physical protein interaction. The literature robustly supports that intermediate-length CAG repeats in ATXN2 modify the SCA3 phenotype, primarily by lowering the age of onset. The claim is factually correct in all aspects except for the 'arrow' field, which has been refined.",
          "cellular_process": "ATXN2 and ATXN3 are both polyglutamine disease proteins. Genetic studies have shown that intermediate-length CAG expansions in the ATXN2 gene act as a genetic modifier, influencing the age of onset and phenotype of Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Intermediate-length ATXN2 polyQ repeats (29-to-31Q) modulate the age of onset in SCA3/MJD.",
            "A 9-base pair duplication in ATXN2 may act as an additional modifier in SCA3 carriers with intermediate ATXN2 alleles."
          ],
          "effect_description": "This genetic interaction, where the polyglutamine tract in ATXN2 exacerbates the pathogenic processes initiated by polyQ-expanded ATXN3, often leads to an earlier age of disease onset.",
          "interaction_effect": "activation",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "Co-occurrence of pathogenic ATXN3 polyQ expansion and intermediate ATXN2 polyQ expansion → Synergistic pathogenic mechanism → Accelerated neurodegeneration → Modified SCA3 phenotype (e.g., earlier age of onset)"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 2,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:45.031055"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 2
    }
  },
  {
    "interaction_id": 27,
    "main_protein": "ATXN3",
    "partner_protein": "KEAP1",
    "original_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western Blot",
              "authors": "Toulis V, et al.",
              "journal": "Cell Rep",
              "species": "mouse",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            }
          ],
          "function": "KEAP1 Protein Level Maintenance",
          "validity": "FALSE",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "net_effect": "activation",
          "effect_type": "",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_salvaged_from_false",
          "function_effect": "activation",
          "validation_note": "The claim is marked FALSE because it fundamentally misrepresents the literature. It claims that ATXN3's function is to destabilize KEAP1, based on the observation that ATXN3 depletion leads to lower KEAP1 levels. This is a logical inversion. The evidence shows that ATXN3 is required to *maintain* KEAP1 levels. The claim's 'Cellular Process' and 'Effect Description' are contradictory. While some individual fields are correct, the overall functional claim is incorrect. A corrected function is provided to accurately reflect that ATXN3 maintains KEAP1 levels.",
          "cellular_process": "ATXN3 is required for the maintenance of KEAP1 protein levels. Abrogation of Atxn3 expression leads to decreased levels of the regulatory protein KEAP1 in the retina.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of KEAP1 in the retina."
          ],
          "effect_description": "By maintaining appropriate levels of KEAP1, the primary negative regulator of NRF2, ATXN3 helps to regulate the basal activity of the NRF2 antioxidant response pathway.",
          "biological_consequence": [
            "ATXN3 maintains KEAP1 protein levels",
            "KEAP1 sequesters NRF2 in the cytoplasm",
            "KEAP1 facilitates NRF2 ubiquitination and degradation",
            "Basal antioxidant gene expression is suppressed"
          ],
          "original_function_name": "KEAP1 Protein Stability",
          "_was_false_but_corrected": true
        },
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:50.094341"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western Blot",
              "authors": "Toulis V, et al.",
              "journal": "Cell Rep",
              "species": "mouse",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            }
          ],
          "function": "KEAP1 Protein Level Maintenance",
          "validity": "FALSE",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "net_effect": "activation",
          "effect_type": "",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_salvaged_from_false",
          "function_effect": "activation",
          "validation_note": "The claim is marked FALSE because it fundamentally misrepresents the literature. It claims that ATXN3's function is to destabilize KEAP1, based on the observation that ATXN3 depletion leads to lower KEAP1 levels. This is a logical inversion. The evidence shows that ATXN3 is required to *maintain* KEAP1 levels. The claim's 'Cellular Process' and 'Effect Description' are contradictory. While some individual fields are correct, the overall functional claim is incorrect. A corrected function is provided to accurately reflect that ATXN3 maintains KEAP1 levels.",
          "cellular_process": "ATXN3 is required for the maintenance of KEAP1 protein levels. Abrogation of Atxn3 expression leads to decreased levels of the regulatory protein KEAP1 in the retina.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of KEAP1 in the retina."
          ],
          "effect_description": "By maintaining appropriate levels of KEAP1, the primary negative regulator of NRF2, ATXN3 helps to regulate the basal activity of the NRF2 antioxidant response pathway.",
          "biological_consequence": [
            "ATXN3 maintains KEAP1 protein levels",
            "KEAP1 sequesters NRF2 in the cytoplasm",
            "KEAP1 facilitates NRF2 ubiquitination and degradation",
            "Basal antioxidant gene expression is suppressed"
          ],
          "original_function_name": "KEAP1 Protein Stability",
          "_was_false_but_corrected": true
        },
        {
          "arrow": "inhibits",
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium. | Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "direct_effect": "inhibition",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:45:50.094341"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "KEAP1"
      ],
      "upstream_interactor": "KEAP1",
      "depth": 2
    }
  },
  {
    "interaction_id": 39,
    "main_protein": "ATXN3",
    "partner_protein": "PRKN",
    "original_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 5,
        "validated_at": "2025-11-18T05:45:52.039931"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 5,
        "validated_at": "2025-11-18T05:45:52.039931"
      },
      "_arrow_validated": true
    },
    "corrections_count": 5,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 10,
    "main_protein": "ATXN3",
    "partner_protein": "NCOA1",
    "original_data": {
      "primary": "NCOA1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T05:45:56.046399"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "NCOA1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T05:45:56.046399"
      },
      "_arrow_validated": true
    },
    "corrections_count": 3,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 35,
    "main_protein": "ATXN3",
    "partner_protein": "UBQLN2",
    "original_data": {
      "primary": "UBQLN2",
      "direction": "none",
      "arrow": "no interaction",
      "interaction_type": "no interaction",
      "functions": [
        {
          "name": "UBQLN2-mediated Clearance of ATXN3 Aggregates",
          "arrow": "no effect",
          "evidence": [
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Immunohistochemistry, Co-Immunoprecipitation",
              "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
              "journal": "Neurobiology of Disease",
              "species": "human, mouse, cultured cells (HEK293)",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2. | Consistent with this result, in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            }
          ],
          "function": "Protein Aggregation and Clearance",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "consequences": "The premise of this function is incorrect. UBQLN2 does not interact with ATXN3 or its aggregates in SCA3, meaning ATXN3 does not regulate UBQLN2's role in protein clearance. The observed absence of UBQLN2 in SCA3 inclusions is due to a lack of interaction, not a regulatory event.",
          "direct_arrow": "no_effect",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "no_effect",
            "mediator_chain": []
          },
          "direct_effect": "no_effect",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim accurately represents a key negative finding in the literature. All aspects of the claim, from the lack of physical interaction to the differential recruitment of UBQLN2 to inclusions in SCA3 vs. HD, are strongly supported by experimental evidence. The only minor inaccuracy is the use of the word 'inhibits' for the arrow, which has been corrected in the refined function.",
          "cellular_process": "UBQLN2 is a key component of the cellular protein quality control system, shuttling ubiquitinated proteins to the proteasome. Despite the involvement of both ATXN3 and UBQLN2 in proteostasis, co-immunoprecipitation and co-localization studies have shown they do not physically interact. UBQLN2 is selectively recruited to inclusions in Huntington's disease (HD) but is absent from the ATXN3-positive inclusions in Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Co-precipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
            "UBQLN2 is selectively recruited to nuclear inclusions in Huntington's disease but not in Spinocerebellar Ataxia Type 3.",
            "ATXN3 is not a substrate for UBQLN2-mediated clearance."
          ],
          "effect_description": "This is a negative finding; UBQLN2 does not interact with ATXN3. This lack of interaction distinguishes the pathology of SCA3 from other polyglutamine diseases like HD.",
          "interaction_effect": "none",
          "interaction_direction": "none",
          "biological_consequence": [
            "Lack of ATXN3-UBQLN2 physical interaction → Failure to recruit UBQLN2 to ATXN3-positive inclusions → Absence of UBQLN2 in SCA3 inclusions → Differential protein quality control response in SCA3 vs. Huntington's disease"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "no interaction",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 4,
        "validated_at": "2025-11-18T05:46:05.763158"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "UBQLN2",
      "direction": "none",
      "arrow": "no interaction",
      "interaction_type": "no interaction",
      "functions": [
        {
          "name": "UBQLN2-mediated Clearance of ATXN3 Aggregates",
          "arrow": "no effect",
          "evidence": [
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Immunohistochemistry, Co-Immunoprecipitation",
              "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
              "journal": "Neurobiology of Disease",
              "species": "human, mouse, cultured cells (HEK293)",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2. | Consistent with this result, in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            }
          ],
          "function": "Protein Aggregation and Clearance",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "net_effect": "inhibition",
          "consequences": "The premise of this function is incorrect. UBQLN2 does not interact with ATXN3 or its aggregates in SCA3, meaning ATXN3 does not regulate UBQLN2's role in protein clearance. The observed absence of UBQLN2 in SCA3 inclusions is due to a lack of interaction, not a regulatory event.",
          "direct_arrow": "no_effect",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "no_effect",
            "mediator_chain": []
          },
          "direct_effect": "no_effect",
          "evidence_source": "fact_checker_verified",
          "function_effect": "inhibition",
          "validation_note": "The claim accurately represents a key negative finding in the literature. All aspects of the claim, from the lack of physical interaction to the differential recruitment of UBQLN2 to inclusions in SCA3 vs. HD, are strongly supported by experimental evidence. The only minor inaccuracy is the use of the word 'inhibits' for the arrow, which has been corrected in the refined function.",
          "cellular_process": "UBQLN2 is a key component of the cellular protein quality control system, shuttling ubiquitinated proteins to the proteasome. Despite the involvement of both ATXN3 and UBQLN2 in proteostasis, co-immunoprecipitation and co-localization studies have shown they do not physically interact. UBQLN2 is selectively recruited to inclusions in Huntington's disease (HD) but is absent from the ATXN3-positive inclusions in Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Co-precipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
            "UBQLN2 is selectively recruited to nuclear inclusions in Huntington's disease but not in Spinocerebellar Ataxia Type 3.",
            "ATXN3 is not a substrate for UBQLN2-mediated clearance."
          ],
          "effect_description": "This is a negative finding; UBQLN2 does not interact with ATXN3. This lack of interaction distinguishes the pathology of SCA3 from other polyglutamine diseases like HD.",
          "interaction_effect": "none",
          "interaction_direction": "none",
          "biological_consequence": [
            "Lack of ATXN3-UBQLN2 physical interaction → Failure to recruit UBQLN2 to ATXN3-positive inclusions → Absence of UBQLN2 in SCA3 inclusions → Differential protein quality control response in SCA3 vs. Huntington's disease"
          ]
        }
      ],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "no interaction",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 4,
        "validated_at": "2025-11-18T05:46:05.763158"
      },
      "_arrow_validated": true
    },
    "corrections_count": 4,
    "chain_context": {
      "interaction_type": "no interaction",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 38,
    "main_protein": "ATXN3",
    "partner_protein": "PINK1",
    "original_data": {
      "primary": "PINK1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:46:13.247407"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PINK1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [],
      "evidence": [],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T05:46:13.247407"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "PRKN"
      ],
      "upstream_interactor": "PRKN",
      "depth": 2
    }
  }
]